96
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma

, , , , , & show all
Pages 9145-9152 | Published online: 01 Dec 2021

References

  • Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4):452–463. doi:10.21037/hbsn-20-480
  • Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370.
  • Dedkova LM, Hecht SM. Expanding the scope of protein synthesis using modified ribosomes. J Am Chem Soc. 2019;141(16):6430–6447. doi:10.1021/jacs.9b02109
  • Huang G, Li H, Zhang H. Abnormal expression of mitochondrial ribosomal proteins and their encoding genes with cell apoptosis and diseases. Int J Mol Sci. 2020;21(22):8879. doi:10.3390/ijms21228879
  • Petibon C, Malik Ghulam M, Catala M, Abou Elela S. Regulation of ribosomal protein genes: an ordered anarchy. Wiley Interdiscip Rev RNA. 2020;12:e1632.
  • Catez F, Dalla Venezia N, Marcel V, et al. Ribosome biogenesis: an emerging druggable pathway for cancer therapeutics. Biochem Pharmacol. 2019;159:74–81. doi:10.1016/j.bcp.2018.11.014
  • Xie C, Cao K, Peng D, Qin L. RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells. Exp Ther Med. 2021;22(1):752. doi:10.3892/etm.2021.10184
  • Guo P, Wang Y, Dai C, et al. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/beta-catenin-induced FGF18 expression in hepatocellular carcinoma. Oncogene. 2018;37(9):1220–1236. doi:10.1038/s41388-017-0017-y
  • Fernandez-Pol JA, Klos DJ, Hamilton PD. A growth factor-inducible gene encodes a novel nuclear protein with zinc finger structure. J Biol Chem. 1993;268(28):21198–21204. doi:10.1016/S0021-9258(19)36910-8
  • Yang ZY, Jiang H, Qu Y, et al. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin beta4. Carcinogenesis. 2013;34(12):2851–2860. doi:10.1093/carcin/bgt226
  • Fernandez-Pol JA. Increased serum level of RPMPS-1/S27 protein in patients with various types of cancer is useful for the early detection, prevention and therapy. Cancer Genomics Proteomics. 2012;9(4):203–256.
  • Stack BC, Hollenbeak CS, Lee CM, et al. Metallopanstimulin as a marker for head and neck cancer. World J Surg Oncol. 2004;2:45. doi:10.1186/1477-7819-2-45
  • Ganger DR, Hamilton PD, Fletcher JW, Fernandez-Pol JA. Metallopanstimulin is overexpressed in a patient with colonic carcinoma. Anticancer Res. 1997;17(3C):1993–1999.
  • Sundblad AS, Ricci L, Xynos FP, Fernandez-Pol JA. Metallopanstimulin/S27 ribosomal antigen expression in stages I and II breast cancer: its relationship with clinicopathologic factors. Cancer Genomics Proteomics. 2005;2(1):53–60.
  • Liu Y, Ma J, Zhang L, Lin J, Liu X. Overexpressed MPS-1 contributes to endometrioma development through the NF-kappaB signaling pathway. Reprod Biol Endocrinol. 2021;19(1):111. doi:10.1186/s12958-021-00796-z
  • Feldheim J, Kessler AF, Schmitt D, et al. Ribosomal protein S27/metallopanstimulin-1 (RPS27) in glioma-A new disease biomarker? Cancers (Basel). 2020;12(5):1085. doi:10.3390/cancers12051085
  • Ganger DR, Hamilton PD, Klos DJ, et al. Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia. Cancer Detect Prev. 2001;25(3):231–236.
  • Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166–180. doi:10.1593/neo.07112
  • Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W560. doi:10.1093/nar/gkz430
  • Yang Z, Li C, Yan C, et al. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochim Biophys Acta Mol Basis Dis. 2019;1865(1):181–192. doi:10.1016/j.bbadis.2018.10.039
  • Wurmbach E, Chen YB, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007;45(4):938–947. doi:10.1002/hep.21622
  • Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012;44(6):694–698. doi:10.1038/ng.2256
  • Roessler S, Jia HL, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202–10212. doi:10.1158/0008-5472.CAN-10-2607
  • Zhan YT, Li L, Zeng TT, et al. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma. Aging (Albany NY). 2020;13(1):537–554. doi:10.18632/aging.202164
  • Yang ZY, Qu Y, Zhang Q, et al. Knockdown of metallopanstimulin-1 inhibits NF-kappaB signaling at different levels: the role of apoptosis induction of gastric cancer cells. Int J Cancer. 2012;130(12):2761–2770. doi:10.1002/ijc.26331